Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD

Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Katarzyna Puzniakowska, Marta Gruchala-Niedoszytko, Michal Makowiecki, Katarzyna Swietnicka, Ewa Jassem

Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Session: COPD: exacerbations, gas exchange and associated dysfunction
Session type: Thematic Poster Session
Number: 669
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Iwona Damps-Konstanska (Gdynia, Poland), Iwona Damps-Konstanska, Katarzyna Puzniakowska, Marta Gruchala-Niedoszytko, Michal Makowiecki, Katarzyna Swietnicka, Ewa Jassem. Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD. Eur Respir J 2015; 46: Suppl. 59, 669

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Analysis of serum prohepcidin and hepcidin levels in COPD patients by stages and by patient cathegory
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Serum vitamin D level is associated with emphysema progression in male patients with COPD
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Plasma surfactant protein-D (SPD) concentration and severity of airflow limitation in COPD patients (pts)
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Relation betweeen vitamin D levels and clinical properties of COPD patients
Source: International Congress 2015 – Different data in COPD
Year: 2015


Plasma surfactant protein D (SP-D) and smoking status in patients with COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

The relationship between systemic inflammation and vitamin D levels in COPD
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013

The effect of Vitamin D deficiency on lung function in current smoker COPD patients
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD
Source: International Congress 2014 – Predictors
Year: 2014

Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014


Vitamin D deficiency is associated with rapid decline in exercise capacity in male patients with COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013

Profile of serum vitamin D levels in stable COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Relationship between plasma amino acid levels and lung function decline in patients with COPD
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013


Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014

Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015


Serum sirtuin-1 is reduced in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016


Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013